1991
DOI: 10.1016/0022-510x(91)90283-d
|View full text |Cite
|
Sign up to set email alerts
|

Dopa-sensitive and Dopa-resistant gait parameters in Parkinson's disease

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

29
152
4
5

Year Published

2000
2000
2014
2014

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 250 publications
(190 citation statements)
references
References 22 publications
29
152
4
5
Order By: Relevance
“…Levodopa intake increases velocity, stride length, and decreases the duration of the double limb support [2, 7-8, 14, 16, 19, 23, 34, 37]. However, after the administration of levodopa, cadence was increased in some reports [19] and not changed in the others [7,34] as in our study. Chronic bilateral STN stimulation improves akinesia, rigidity and tremor in patients with severe PD [21,[24][25][26][27][29][30].…”
Section: Discussioncontrasting
confidence: 38%
See 1 more Smart Citation
“…Levodopa intake increases velocity, stride length, and decreases the duration of the double limb support [2, 7-8, 14, 16, 19, 23, 34, 37]. However, after the administration of levodopa, cadence was increased in some reports [19] and not changed in the others [7,34] as in our study. Chronic bilateral STN stimulation improves akinesia, rigidity and tremor in patients with severe PD [21,[24][25][26][27][29][30].…”
Section: Discussioncontrasting
confidence: 38%
“…The fundamental problem in gait disturbance of PD is regulation of stride length [31]. Levodopa increases stride length and velocity (kinematic parameters), while temporal parameters related to rhythm are levodopa resistant [7].…”
Section: Introductionmentioning
confidence: 99%
“…Gait variability may help to enhance the early identification of potential fallers in PD, as it does in other populations. A few studies have observed increased variability in patients with PD compared to controls, noting that this variability tends to increase with disease severity (Blin et al, 1990;Blin, Ferrandez, Pailhous, & Serratrice, 1991;Hausdorff et al, 1998). In general, however, the relationships between gait variability, fall risk, and other parkinsonian features were not wellstudied and the effect of levodopa on falls and gait variability were also largely unknown.…”
Section: Gait Variability and Fall Risk In Parkinson's Disease (Pd)mentioning
confidence: 99%
“…Regarding parkinsonian signs, patients with Parkinson's disease (PD) manifest slower gait velocity due to a reduction of step length with an unchanged cadence (Stolze et al 2001). While some of these gait disturbances are dopa-sensitive, others are dopa-resistant (Blin et al 1991), suggesting alternative or additional mechanisms than just dopamine deficiency. However, the relationship between quantitative gait parameters and individual MPS in aging is not known at present.…”
Section: Introductionmentioning
confidence: 99%